세계의 고가치 식물 화합물 시장 규모는 2023년 165억 3,670만 달러에서 예측 기간 중 11.69%의 CAGR로 추이하며, 2032년에는 447억 2,470만 달러 규모로 성장할 것으로 예측됩니다.
식물 유래 보충제나 뉴트라슈티컬의 수요는 세계의 건강과 웰니스 동향에 의해 촉진되고 있습니다. 종합적인 건강을 증진하고 건강 문제를 해결하는 건강 보조 식품은 고품질의 식물성 화합물을 사용하여 제조됩니다. 의약품, 건강보조식품, 화장품, 식품 및 음료 등 다양한 산업에서 천연 유기농 제품에 대한 수요가 세계 고부가가치 식물 화합물 시장의 주요 촉진요인으로 작용하고 있습니다. 이러한 화합물의 건강상의 이점에 대한 소비자의 인식이 높아지면서 합성 제품보다 천연 제품을 선호하는 경향이 높아짐에 따라 시장이 성장하고 있습니다. 반면, 추출 공정의 높은 비용, 규제 장벽, 식물 원료의 지속가능한 조달에 대한 우려 등 여러 가지 과제가 있습니다. 시장 진출기업은 추출 기술의 기술적 진보와 R&D 활동에 대한 집중적인 노력으로 인해 유리한 기회를 얻을 수 있을 것으로 예상됩니다.
지역별 전망
북미 지역은 2022년에 최대 규모를 보이며, 시장 규모는 43억 달러였습니다. 2022-2032년에는 CAGR 11.21%로 대폭적인 성장을 보일 것으로 예측됩니다. 자연 요법, 식이보충제, 웰니스 제품에 대한 관심의 증가가 북미에서 고가치 식물 화합물 시장의 확대를 촉진하는 주요 요인이 되고 있습니다.
유럽은 2022년에 34억 달러 규모를 보이며, 예측 기간 중 10.74%의 CAGR로 일관한 성장을 보일 것으로 예측됩니다. 시장의 확대는 특히 화장품이나 식이보충제에서 유럽의 소비자가 고가치 식물 화합물을 채택했기 때문입니다.
아시아태평양은 2022년에 67억 달러 시장 규모를 보이며, 예측 기간 중 CAGR 12.02%로 성장할 것으로 예측됩니다. 이 지역의 견고한 CAGR은 제약 업계나 식품 업계에서 허브 요법 및 아유르베다 요법이 널리 채택되고 있는 것, 인도 및 중국 등의 국가에서 이러한 요법의 인기가 높아지고 있는 것 등에 기인하고 있습니다.
세계의 고가치 식물 화합물 시장을 조사했으며, 시장의 정의와 개요, 시장 성장에 대한 각종 영향요인 분석, 시장 규모 추이·예측, 각종 구분·지역/주요 국가별 내역, 경쟁 환경, 주요 기업의 개요 등을 정리하여 전해드립니다.
Global High Value Plant Compound Market Research Report Information by Source (Leaves, Rhizomes & Roots, Barks & Stems, Fruits, Flowers, & Bulbs, Other Sources), Type (Phenylpropanoids, Alkaloids, Terpenoids, Polyketides), Application (Pharmaceuticals, Cosmetics, Food & Beverages, Dietary Supplements, Others, Forecast Till 2032
In 2023, the High Value Plant Compound Market Size was estimated to be USD 16,536.70 million. The Global High Value Plant Compound industry is anticipated to experience a compound annual growth rate (CAGR) of 11.69% from 2024 to 2032, resulting in a total value of USD 44,724.70 million.
The demand for plant-based supplements and nutraceuticals is being driven by the global health and wellness trend. Dietary supplements that promote overall health and address health issues are prepared using high-quality plant compounds. The demand for natural and organic products in a variety of industries, including pharmaceuticals, nutraceuticals, cosmetics, and food and beverages, is the primary driver of the global high-value plant compounds market. The market has experienced growth as a result of the increasing consumer awareness of the health benefits of these compounds and the increasing preference for natural products over synthetic ones. Nevertheless, the market is confronted with a variety of obstacles, including the high cost of extraction processes, regulatory obstacles, and concerns regarding the sustainable procurement of plant materials. It is anticipated that market participants will experience lucrative opportunities as a result of technological advancements in extraction techniques and a focus on research and development activities.
Market segment insights
Table 1 illustrates a substantial upward trajectory in the global market for high-value plant compounds from 2022 to 2032. The market, which was valued at USD 14,919.4 million in 2022, is expected to experience a Compound Annual Growth Rate (CAGR) of 11.7% from 2023 to 2032, culminating in a spectacular USD 44,724.7 million in 2032. These compounds, which are derived from a variety of plant sources, are of significant value because they are used in industries such as pharmaceuticals, cosmetics, and food.
Leaves comprise the greatest portion of this market among the various plant sources. Leaves generated USD 4,730.6 million in 2022, and this sector is anticipated to expand at a compound annual growth rate (CAGR) of 11.8%. The substantial increase in the leaves category can be attributed to the growing demand for herbal and botanical constituents in healthcare and wellness products. Rhizomes & Roots, Barks & Stems, Fruits, Flowers, & Bulbs, and Other Sources are also significant contributors to this market, with CAGRs of 12.2%, 10.7%, 12.0%, and 11.5%, respectively.
One of the fastest-growing segments in the market is phenylpropanoids, including curcumin and resveratrol, with a compound annual growth rate (CAGR) of 11.7%. The antioxidant and anti-inflammatory properties of these compounds have made them a popular ingredient in dietary supplements and cosmetic products. Alkaloids and terpenoids are also positioned for significant growth, with anticipated compound annual growth rates (CAGRs) of 11.8% and 11.6%, respectively.
Regional Perspectives
In 2022, North America was the greatest market, with a market valuation of $4.3 billion. between 2022 and 2032, the region experienced substantial growth, with a Compound Annual Growth Rate (CAGR) of 11.21%. The burgeoning interest in natural remedies, dietary supplements, and wellness products is the primary factor driving the expansion of the high-value plant compounds market in North America.
Europe, which had a market value of $3.4 billion in 2022, exhibited a compound annual growth rate (CAGR) of 10.74% during the same period, indicating consistent growth. The market has expanded because of the adoption of high-value plant compounds by European consumers, particularly in cosmetics and dietary supplements.
The market value of $6.7 billion in 2022 was achieved by the Asia-Pacific region, which exhibited the maximum CAGR at 12.02% during the same period. The region's robust CAGR can be attributed to the extensive adoption of herbal and Ayurvedic remedies in the pharmaceutical and food industries, as well as the increasing popularity of these remedies in countries such as India and China.
Merck KGaA, MedChemExpress, Selleck Chemicals, Biosynth, Tokyo Chemical Industry, Advion, Inc, Alkaloids Corporation, C-Squared Pharma S.a R.L., Linnea SA, and Inga Pharmaceuticals are among the key companies in the High Value Plant Compound market.